ZA957604B - Injectable liposomal pharmaceutical preparations - Google Patents
Injectable liposomal pharmaceutical preparationsInfo
- Publication number
- ZA957604B ZA957604B ZA957604A ZA957604A ZA957604B ZA 957604 B ZA957604 B ZA 957604B ZA 957604 A ZA957604 A ZA 957604A ZA 957604 A ZA957604 A ZA 957604A ZA 957604 B ZA957604 B ZA 957604B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical preparations
- phospholipid
- liposomal pharmaceutical
- injectable liposomal
- injectable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4432378A DE4432378A1 (de) | 1994-09-12 | 1994-09-12 | Injizierbare liposomale Arzneizubereitungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA957604B true ZA957604B (en) | 1996-04-15 |
Family
ID=6527981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA957604A ZA957604B (en) | 1994-09-12 | 1995-09-11 | Injectable liposomal pharmaceutical preparations |
Country Status (28)
Country | Link |
---|---|
US (1) | US5653998A (da) |
EP (1) | EP0700679B1 (da) |
JP (1) | JPH0881361A (da) |
KR (1) | KR960009998A (da) |
CN (1) | CN1079668C (da) |
AT (1) | ATE187327T1 (da) |
AU (1) | AU698441B2 (da) |
CA (1) | CA2157849A1 (da) |
CZ (1) | CZ287975B6 (da) |
DE (2) | DE4432378A1 (da) |
DK (1) | DK0700679T3 (da) |
EE (1) | EE03377B1 (da) |
ES (1) | ES2139800T3 (da) |
FI (1) | FI954204A (da) |
GR (1) | GR3032664T3 (da) |
HU (1) | HUT73808A (da) |
IL (1) | IL115222A (da) |
MY (1) | MY111841A (da) |
NO (1) | NO311556B1 (da) |
NZ (1) | NZ272943A (da) |
PL (1) | PL181541B1 (da) |
PT (1) | PT700679E (da) |
RU (1) | RU2160099C2 (da) |
SI (1) | SI0700679T1 (da) |
SK (1) | SK281611B6 (da) |
TW (1) | TW359616B (da) |
UA (1) | UA29469C2 (da) |
ZA (1) | ZA957604B (da) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
DE19709704C2 (de) | 1997-03-10 | 1999-11-04 | Michael Georgieff | Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie |
US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
KR20000003433A (ko) * | 1998-06-29 | 2000-01-15 | 김영환 | 반도체소자의 커패시터 제조방법 |
CA2350430C (en) * | 1998-11-13 | 2008-06-03 | Optime Therapeutics, Inc. | Method and apparatus for liposome production |
JP2003508349A (ja) * | 1999-05-14 | 2003-03-04 | エスペリオン エルユーブイ ディベロップメント, インコーポレイテッド | アンギナおよび/またはアンギナ等価状態を処置する方法、ならびにそれに関連する薬学的組成物およびキット |
DE60123583T2 (de) * | 2000-02-04 | 2007-08-09 | Lipoxen Technologies Ltd. | Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome |
US20060177416A1 (en) | 2003-10-14 | 2006-08-10 | Medivas, Llc | Polymer particle delivery compositions and methods of use |
AU2003280505B2 (en) * | 2002-06-26 | 2009-01-15 | Syncore Biotechnology Co., Ltd | Method of producing a cationic liposomal preparation comprising a lipophilic compound |
DE10255195A1 (de) | 2002-11-27 | 2004-06-09 | Lipoid Gmbh | Micellare wasserlösliche Konzentrate |
JP2007522085A (ja) * | 2003-06-27 | 2007-08-09 | スミスクライン・ビーチャム・コーポレイション | 安定化されたトポテカンリポソーム組成物および方法 |
US7345093B2 (en) * | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
EP1868571A4 (en) * | 2005-03-02 | 2011-10-26 | Univ Northeastern | MITOCHONDRIOTROPIC PHOSPHOLIPIDE VESICLES |
CA2608631C (en) * | 2005-06-09 | 2014-07-29 | Biolipox Ab | Method and composition for treating inflammatory disorders |
EP1926780B1 (en) | 2005-09-22 | 2013-08-14 | Medivas, LLC | Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use |
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
EP2034961A1 (de) * | 2006-06-30 | 2009-03-18 | Gertrud Langhoff | Solubilisatformulierungen |
JP6081058B2 (ja) * | 2009-03-19 | 2017-02-15 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
US8591942B2 (en) * | 2009-09-23 | 2013-11-26 | Indu JAVERI | Methods for the preparation of liposomes comprising docetaxel |
US10143652B2 (en) | 2009-09-23 | 2018-12-04 | Curirx Inc. | Methods for the preparation of liposomes |
US20110070294A1 (en) * | 2009-09-23 | 2011-03-24 | Javeri Indu | Methods for the Administration of Drugs Using Liposomes |
IT1404011B1 (it) | 2010-12-03 | 2013-11-08 | Uni Degli Studi Magna Graecia Di Catanzaro | Nanovettore coniugato con tsh per il trattamento del cancro della tiroide |
PL226015B1 (pl) * | 2011-03-03 | 2017-06-30 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną | Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna |
US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
EP3159368B1 (en) | 2011-06-23 | 2024-07-24 | DSM IP Assets B.V. | New biodegradable polyesteramide copolymers for drug delivery |
FR2979239A1 (fr) * | 2011-08-25 | 2013-03-01 | Trophos | Liposome comprenant au moins un derive de cholesterol |
EP2682106A1 (en) | 2012-07-03 | 2014-01-08 | Phares Pharmaceutical Research N.V. | Method of solubilizing biologically active compounds |
WO2014085914A1 (en) * | 2012-12-06 | 2014-06-12 | Misudan Enterprises Inc. | Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation |
EP3233067B1 (en) | 2014-12-18 | 2019-11-06 | DSM IP Assets B.V. | Drug delivery system for delivery of acid sensitive drugs |
CN110898011B (zh) * | 2019-11-27 | 2022-02-08 | 西南医科大学 | 一种依托咪酯纳米制剂及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3515335C2 (de) * | 1985-04-27 | 1995-01-26 | Bayer Ag | Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung |
DE4117750A1 (de) * | 1991-05-30 | 1992-12-24 | Bayer Ag | Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
DE4207481A1 (de) * | 1992-03-10 | 1993-09-16 | Bayer Ag | Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung |
-
1994
- 1994-09-12 DE DE4432378A patent/DE4432378A1/de not_active Withdrawn
-
1995
- 1995-08-28 MY MYPI95002551A patent/MY111841A/en unknown
- 1995-08-30 EP EP95113608A patent/EP0700679B1/de not_active Expired - Lifetime
- 1995-08-30 DK DK95113608T patent/DK0700679T3/da active
- 1995-08-30 SI SI9530334T patent/SI0700679T1/xx unknown
- 1995-08-30 DE DE59507372T patent/DE59507372D1/de not_active Expired - Fee Related
- 1995-08-30 TW TW084109031A patent/TW359616B/zh active
- 1995-08-30 ES ES95113608T patent/ES2139800T3/es not_active Expired - Lifetime
- 1995-08-30 AT AT95113608T patent/ATE187327T1/de not_active IP Right Cessation
- 1995-08-30 PT PT95113608T patent/PT700679E/pt unknown
- 1995-09-05 AU AU30464/95A patent/AU698441B2/en not_active Ceased
- 1995-09-05 US US08/523,662 patent/US5653998A/en not_active Expired - Fee Related
- 1995-09-06 JP JP7252061A patent/JPH0881361A/ja active Pending
- 1995-09-06 UA UA95094063A patent/UA29469C2/uk unknown
- 1995-09-06 NZ NZ272943A patent/NZ272943A/en unknown
- 1995-09-08 PL PL95310344A patent/PL181541B1/pl unknown
- 1995-09-08 IL IL11522295A patent/IL115222A/xx active IP Right Grant
- 1995-09-08 FI FI954204A patent/FI954204A/fi unknown
- 1995-09-08 CA CA002157849A patent/CA2157849A1/en not_active Abandoned
- 1995-09-11 NO NO19953578A patent/NO311556B1/no not_active IP Right Cessation
- 1995-09-11 SK SK1127-95A patent/SK281611B6/sk unknown
- 1995-09-11 RU RU95115542/14A patent/RU2160099C2/ru active
- 1995-09-11 CZ CZ19952341A patent/CZ287975B6/cs not_active IP Right Cessation
- 1995-09-11 ZA ZA957604A patent/ZA957604B/xx unknown
- 1995-09-11 EE EE9500063A patent/EE03377B1/xx not_active IP Right Cessation
- 1995-09-11 KR KR1019950029487A patent/KR960009998A/ko active IP Right Grant
- 1995-09-12 HU HU9502654A patent/HUT73808A/hu unknown
- 1995-09-12 CN CN95115156A patent/CN1079668C/zh not_active Expired - Fee Related
-
2000
- 2000-02-14 GR GR20000400362T patent/GR3032664T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL115222A0 (en) | Injectable liposomal pharmaceutical preparations | |
US4956173A (en) | Composition and use of ademetionine against ageing of the skin | |
CA2162993A1 (en) | Solid fat nanoemulsions as drug delivery vehicles | |
EP0742011A4 (en) | ABSORBABLE PERCUTANEOUS PREPARATION | |
CA2133177A1 (en) | Rapamycin formulations for oral administration | |
ES2101574T3 (es) | Composicion administrable por via oral apta para formar una microemulsion. | |
DK0830145T3 (da) | Formuleringer omfattende leflunomid | |
KR970706792A (ko) | 수불용성 캄프토테신의 지질 복합체의 동결 건조물(Lyophilizate of lipid complex of water insoluble camptothecins) | |
ES2086802T3 (es) | Formulaciones liposomicas de principios activos y procedimiento para su preparacion. | |
FI861695A0 (fi) | Farmaceutiskt preparat och foerfarande foer administrering daerav. | |
CA2251656A1 (en) | Pharmaceutical compositions containing tyloxapol for administration to the respiratory tract | |
CA2203566A1 (en) | Percutaneously administration preparation | |
TH20333B (th) | สารเตรียมทางยาไลโปโซมอลที่สามารถฉีดได้ | |
US20020058633A1 (en) | Compositions based on glycoglyceride and methods of use therefor, in particular cosmetic uses | |
ES2141049A1 (es) | Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes. | |
TH20333A (th) | สารเตรียมทางยาไลโปโซมอลที่สามารถฉีดได้ |